Peter Doshi, Phd
Peter Doshi, PhD, is an associate professor of pharmaceutical health services research at the University of Maryland School of Pharmacy. His research focuses on the drug approval process, how the risks and benefits of medical products are assessed and communicated, and improving the credibility and accuracy of evidence synthesis and biomedical publications. Doshi campaigns for greater transparency of clinical trial data and has been advocating for full transparency of the data on Covid-19 drugs and vaccines. Doshi leads the Restoring Invisible and Abandoned Trials (RIAT) initiative, which aims to ensure clinical trial publications are accurate, complete, and data are publicly available. He completed a post-doctoral fellowship in comparative effectiveness research at Johns Hopkins University and received his Ph.D. in history, anthropology, and science, technology and society from the Massachusetts Institute of Technology.
Robert Kaplan, Phd
Robert M. Kaplan, PhD is currently a faculty member at the Stanford School of Medicine Clinical Excellence Research Center (CERC). He previously served as Chief Science Officer at the US Agency for Health Care Research and Quality (AHRQ) and as Associate Director of the National Institutes of Health, where he led the behavioral and social sciences programs. He is also a Distinguished Research Professor of Health Policy and Management at UCLA, where he previously led the UCLA/RAND AHRQ health services training program and the UCLA/RAND CDC Prevention Research Center. He was Chair of the Department of Health Services from 2004 to 2009. From 1997 to 2004 he was Professor and Chair of the Department of Family and Preventive Medicine, at the University of California, San Diego. He is a past President of five different national or international professional organizations and has served as Editor-In-Chief for two academic journals. His 20 books and over 565 articles or chapters have been cited more than 69,000 times (H-index>113) and Google scholar includes him in the list of the most cited authors in science. In 2019 Kaplan took on a new role as an opinion editorialist, contributing op ed pieces on about a monthly basis. His work has appeared in The Wall Street Journal, USA Today, the Los Angeles Times, the Boston Globe, the San Jose Mercury News, STAT News (Boston Globe Media), RealClear Politics, MedPage, Health Affairs, and The Hill.
Iona Heath, CBE, FRCGP
Inner city general practitioner in Kentish Town in London (1975-2010); now retired.
Past President of the UK Royal College of General Practitioners (2009-2012).
Iona Heath has written regularly for the British Medical Journal and has contributed essays to many other medical journals across the world. She has been particularly interested to explore the nature of general practice, the importance of medical generalism, issues of justice and liberty in relation to health care, the corrosive influence of the medical industrial complex and the commercialization of medicine, and the challenges posed by disease-mongering, the care of the dying, and violence within families.
Patrick Whelan, MD
Patrick Whelan MD Ph.D. is an Associate Clinical Professor of Pediatrics in the Division of Rheumatology at UCLA. He completed his undergraduate degree in biochemistry at Harvard University, Ph.D. degree at Texas Children’s Hospital in Houston, and MD degree at Baylor College of Medicine. He completed rheumatology training at Harvard and was for twenty years a pediatric rheumatologist at Massachusetts General Hospital in Boston.
He is the past president of the Los Angeles Pediatric Society and helps run their summer program for high school students interested in a career in pediatrics. His research interests pertain to non-inflammatory vasculopathies, particularly Kohlmeier-Degos disease, and he has spearheaded efforts at UCLA to develop multidisciplinary care for patients with the PANS and PANDAS syndromes — conditions that contribute to OCD, tic, and behavioral problems in young children. He also has a longstanding interest in Catholic bioethics.
Ongekend (unprecedented)
De titel van deze blog is ontstaan uit het feit dat De Injecties zoveel random slachtoffers maakt dat het overeenkomsten vertoont met het afschieten van clustermunitie op de complete wereldbevolking. Overal vallen slachtoffers; zonder aanzien des persoons.
Veel aspecten van Covid-19 en de daaropvolgende ontwikkeling van een vaccin zijn ongekend voor een vaccin dat wordt ingezet voor gebruik in de algemene bevolking. Enkele van deze aspecten zijn de volgende.
- het eerste gebruik van PEG (polyethyleenglycol) in een injectie (zie tekst);
- het eerste gebruik van een mRNA-vaccintechnologie tegen een infectieuze agens;
- de eerste keer dat Moderna een product op de markt heeft gebracht;
- de eerste keer dat volksgezondheidsfunctionarissen de ontvangers van de vaccinatie hebben verteld dat zij een bijwerking kunnen verwachten;
- Het eerste vaccin dat openbaar wordt gemaakt zonder meer dan voorlopige gegevens over de werkzaamheid (zie tekst);
- Het eerste vaccin dat geen duidelijke beweringen bevat over de vermindering van infecties, overdraagbaarheid of sterfte;
- Het eerste vaccin tegen het coronavirus dat ooit bij mensen is geprobeerd;
- De eerste injectie van genetisch gemodificeerde polynucleotiden bij de algemene bevolking
Vertaald met http://www.DeepL.com/Translator (gratis versie)
Linda Wastila, BSPharm, MSPH, PhD
Linda Wastila, BSPharm, MSPH, PhD, is Professor and Parke-Davis Chair of Geriatric Pharmacotherapy in the University of Maryland Baltimore School of Pharmacy. For almost thirty years, Dr. Wastila has conducted health services policy research with a focus on pharmaceutical health policy and drug safety. Trained in pharmacy and public health, her expertise in analyzing large databases, including Medicare, Medicaid, and proprietary claims data, has landed her grants and contracts funded by NIDA, NIA, SAMHSA, CMS, FDA, AHRQ, state governments, and foundations. With more than 150 peer-reviewed publications to her credit, she has demonstrated experience in assessing the impacts of public health policies on resources utilization and costs, drug therapy appropriateness, medication adherence, and outcomes, including hospitalization/rehospitalization, morbidity, and mortality. Dr. Wastila has served as technical expert and advisory committee member for FDA, CMS, and CDC.
Restsef Levi, PHD
Retsef Levi PhD is the J. Spencer Standish (1945) Professor of Operations Management at the MIT Sloan School of Management and affiliated faculty at the MIT Operations Research Center. He serves as the MIT Sloan Faculty Co-Director of the Leaders for Global Operations (LGO) program and as the Faculty Director of the MIT Sloan Food Supply Chain Analytics and Sensing (FSAS) Initiative. Before coming to MIT, Levi spent a year in the Department of Mathematical Sciences at the IBM T.J. Watson Research Center as the holder of the Goldstine Postdoctoral Fellowship. He received a Bachelor’s degree in Mathematics from Tel-Aviv University (Israel) in 2001, and a PhD in Operations Research from Cornell University in 2005. Levi spent close to 12 years in the Israeli Defense Forces as an Intelligence Officer in the area of special operations and cyber, where he held multiple leadership positions.
Levi is a world expert and a thought leader in risk management and the applications of advanced data-analytics within large healthcare and public health systems, food and agriculture supply chains, manufacturing of biologic drugs, cybersecurity, as well as logistics, procurement and inventory management. With over 50 articles in top leading journals, his research has had significant methodological contributions, as well as major impact on practice, including multiple field implementations of his research outcomes. During the last 15 months, Levi has consulted to several states in the US and government’s ministers in Israel, supporting critical aspects of COVID-19 related policies and decisions, such as protecting nursing homes, reopening of schools, public health safety and vaccination. Throughout 2020-2021, Levi has led the development and implementation of the operations and health safety protocols at the MIT Sloan School, enabling the reopening of the school to in person classes.
David Healy, MD, FRCPsych
Dr David Healy is a Professor in the Department of Family Medicine at McMaster University in Ontario, having previously been a Professor of Psychiatry at Bangor and Cardiff Universities in the U.K. He studied medicine in University College Dublin, Ireland, and at Cambridge University. He is a former Secretary of the British Association for Psychopharmacology, and author of over 200 peer reviewed articles, 250 other pieces and 24 books, including The Antidepressant Era, and The Creation of Psychopharmacology from Harvard University Press, The Psychopharmacologists Volumes 1-3, Let Them Eat Prozac from New York University Press, Mania from Johns Hopkins University Press, Pharmageddon from California University Press, Children of the Cure and Shipwreck of the Singular from Samizdat Press.
His main areas of research are adverse effects of treatment, clinical trials in psychopharmacology, the history of psychopharmacology, and the impact of both trials and psychotropic drugs on our culture. He is a founder of Data Based Medicine and RxISK.org.
He has been involved as an expert witness in homicide, suicide and birth defect legal actions involving psychotropic drugs, and in bringing problems with these drugs to the attention of American, British and European regulators, as well raising awareness of how pharmaceutical companies sell drugs by marketing diseases and co-opting academic opinion-leaders, ghost-writing their articles.
Aditi Bhargava, PhD
Dr. Aditi Bhargava is a Professor in the Department of Obstetrics and Gynecology and the Center for Reproductive Sciences at UCSF. She is a molecular biologist with research area spanning multiple stress-related diseases. Her research focuses on the role of stress hormones and their receptors in stress, inflammation, immune function, pain, metabolic syndrome, and the brain-gut axis with a focus on understanding how these processes differ in men and women. In 2013, UCSF filed a patent on her behalf for RNAi-based delivery platform for treatment of various diseases. She has published over 60 peer-reviewed research papers and several book chapters. She serves in several leadership roles on Scientific Society committees and at UCSF as well as on the Editorial Board of several scientific journals. She has been recognized with several awards including the New Investigator Award from the American Physiological Society, the FASEB MARC Mentor Award, and has been inducted as a Fellow of the American Gastroenterological Association.
Kim Witczak, Woodymatters
Kim Witczak is an international drug safety advocate and speaker with over 25 years professional experience in advertising and marketing communications. She became involved in pharmaceutical drug safety issues after the sudden death of her husband in 2003 due to an undisclosed drug side effect of antidepressants. She was instrumental in helping to get FDA Blackbox suicide warnings added to antidepressants in 2004 and 2006. Kim has taken her personal experience and launched a national public awareness campaign through www.woodymatters.com, a grassroots organization dedicated to make sure the everyday patient perspective is represented in healthcare conversations. She has testified before US Senate on FDA related issues as well as numerous FDA Advisory Committees. Kim currently serves as Consumer Representative on the FDA Psychopharmacologic Drug Advisory Committee and is a board member with several non-profit organizations in the field of drug and patient safety.
Joel Wallskog, MD
Joel Wallskog is an orthopedic surgeon from Mequon, Wisconsin. He grew up in the Milwaukee area. He attended Marquette University for his undergraduate education. He married his college sweetheart immediately after college graduation in 1992. He then obtained his medical degree at the University of Wisconsin. He completed his orthopedic surgery residency at the Medical College of Wisconsin. He elected to do additional fellowship training specializing in joint replacement at Case Western Reserve University in Cleveland, Ohio. He entered private practice in 2002. He became employed with Aurora Healthcare in 2009 where he has been employed since. He has developed a large successful orthopedic practice focusing on joint replacement, including shoulder, hip and knee replacement. He has extensive experience in revision joint replacement and hip resurfacing. For many years, he has been on the clinical faculty for the Medical College of Wisconsin, training fourth- and fifth-year orthopedic surgery residents on improving their surgical skills. Outside of his professional career, he is a proud father of four children. Prior to his diagnosis of transverse myelitis, he was an avid outdoors person. He enjoyed hiking, biking and numerous watersports such as wake surfing and water skiing.
Joel was exposed to Covid 19 in August/September of 2020, likely at his work. He was exposed to numerous co-workers at that time who were symptomatic and tested positive for Covid 19. He subsequently tested positive for Covid 19 antibodies in September of 2020. He was asymptomatic. According to CDC recommendations at the time, he waited 3 months after his antibody diagnosis to obtain his first Covid vaccine. He developed numbness, weakness and balance difficulties soon after receiving the first Moderna Covid vaccine (received 12/30/2020). In the following months, he experienced periods of quite severe lower thoracic back pain. He was subsequently diagnosed with transverse myelitis with a demyelinated lesion at the T8-T9 level. He was treated with high dose steroids and IVIG with no improvement. He has participated in physical therapy. His symptoms are essentially unchanged since his diagnosis in January 2021. He has been unable to return to work as an orthopedic surgeon and has been on long term disability. He can walk short distances but is unable to return to any of his sporting activities that he enjoyed prior to his diagnosis of transverse myelitis.
Verder Navigeren
Nieuwste Berichten
- De Russische president Vladimir Poetin vecht in Oekraïne tegen de Deep Staat en de Bilderberg Club — The Balkans ChroniclesNa de val van het IJzeren Gordijn in 1989,het Westen breidde triomfantelijk zijn economische, politieke en militaire tentakels steeds verder oostwaarts uit, tot tegen de grenzen van Rusland. Poetin protesteerde, maar het Westen luisterde niet naar de diepe Russische grieven en frustraties. Zo zijn we bij de oorlog in Oekraïne aanbeland.In de jaren ’90, net […]
Wat wil Elon Musk nu met Twitter?- Zelfs EMA waarschuwt: boosters SLOPEN IMMUUNSYSTEEM!
Boosters SLOPEN IMMUUNSYSTEEM!
ONE BIG DISTRACTION. Prepare yourself before the S*** hits the FAN 